HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James Revkin Selected Research

bococizumab

7/2018Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab.
1/2017Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
1/2017Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.
8/2016Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James Revkin Research Topics

Disease

2Stroke (Strokes)
07/2018 - 01/2017
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
07/2018 - 08/2016
2Myocardial Infarction
07/2018 - 01/2017
2Injection Site Reaction
01/2017 - 01/2017
1Fatigue
03/2024
1Nausea
03/2024
1Neoplasms (Cancer)
03/2024
1Body Weight (Weight, Body)
03/2024
1Vomiting
03/2024
1Colorectal Neoplasms (Colorectal Cancer)
03/2024
1Anorexia
03/2024
1Cachexia
03/2024
1Inborn Genetic Diseases (Disease, Hereditary)
07/2018
1Hypertension (High Blood Pressure)
07/2018
1Hyperlipidemias (Hyperlipidemia)
01/2017
1Unstable Angina
01/2017
1Vascular Diseases (Vascular Disease)
08/2016
1Cardiovascular Diseases (Cardiovascular Disease)
08/2016
1Heart Failure
01/2016

Drug/Important Bio-Agent (IBA)

4bococizumabIBA
07/2018 - 08/2016
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2017 - 08/2016
2oxidized low density lipoproteinIBA
07/2018 - 08/2016
2LDL CholesterolIBA
07/2018 - 08/2016
2LipidsIBA
01/2017 - 08/2016
1Growth Differentiation Factor 15IBA
03/2024
1Biomarkers (Surrogate Marker)IBA
03/2024
1CytokinesIBA
03/2024
1CholesterolIBA
08/2016

Therapy/Procedure

4Therapeutics
03/2024 - 01/2016